James C Foster bought $1.0M of CRL
Chairman, President and CEO at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. 6,075 shares at an average of $165.01, traded Feb 20, 2025, filed Feb 21, 2025.
Score components
- +25RoleCEO
- +25Trade size$1.0M at market
- 0Relative to holdingsHoldings up 3.4%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-006253, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | POpen-market purchase Common Stock | +6,075 | $165.01 | $1.0M | 183,639 | Feb 21, 2025 |
Related signals
Other insiders at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Shannon M Parisotto CEVP, Disc & Safety Assessment | $303k 981 shares | -17% | |
| 17Weak | CRLbuy CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Glenn Coleman EVP & Chief Financial Officer | $2,974 10 shares | +0% | |
| 26Weak | CRLsell CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Joseph W LaPlume EVP, Corp Strategy & Develop | $126k 800 shares | -3% | |
| 22Weak | CRLsell CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Joseph W LaPlume EVP, Corp Strategy & Develop | $60k 400 shares | -2% | |
| 3Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | George Massaro director | $19k 140 shares | -2% | |
| 31Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Joseph W LaPlume EVP, Corp Strategy & Develop | $73k 500 shares | -2% | |
| 3Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | George Massaro director | $20k 140 shares | -2% | |
| 41Moderate | CRLsell CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Joseph W LaPlume EVP, Corp Strategy & Develop | $715k 4,400 shares | -18% | |
| 41Moderate | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Birgit Girshick Corporate Executive VP & COO | $249k 1,514 shares | +3% | |
| 50Moderate | CRLsell CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Richard F Wallman director | $1.6M 7,621 shares | -40% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.